Tenepride P 20/15 mg Tablet Substitute
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
PIOGLITAZONE-15MG + TENELIGLIPTIN-20MG
Uses:
<p>Tenepride P 20/15 mg Tablet is used in the treatment of type-2 diabetes mellitus. The detailed uses of Tenepride P 20/15 mg Tablet are as follows:</p><ul><li><strong>Manage type 2 diabetes mellitus:</strong> Tenepride P 20/15 mg Tablet is used to manage type 2 diabetes mellitus in adults.</li><li><strong>insulin sensitivity:</strong> Tenepride P 20/15 mg Tablet improves the body’s sensitivity to insulin, helping cells absorb glucose more effectively.</li></ul>
Medicinal Benefits:
Tenepride P 20/15 mg Tablet contains Pioglitazone (thiazolidinediones) and Teneligliptin (dipeptidyl peptidase 4 inhibitors). It is used to treat type-2 diabetes mellitus. Pioglitazone lowers blood sugar levels by restoring the proper insulin amount in the body. Teneligliptin decreases the release of glucagon, a hormone that raises blood sugar levels, and increases the release of insulin from the pancreas. Together, Tenepride P 20/15 mg Tablet helps treat type-2 diabetes mellitus.
Tenepride P 20/15 mg Tablet is used to treat type-2 diabetes mellitus.
Tenepride P 20/15 mg Tablet works by increasing the body's sensitivity to insulin and facilitates insulin release from the pancreas. Thereby, Tenepride P 20/15 mg Tablet helps treat type-2 diabetes mellitus.
Do not stop taking Tenepride P 20/15 mg Tablet without consulting the doctor, as it may increase blood glucose levels. To treat your condition effectively, continue taking Tenepride P 20/15 mg Tablet for as long as your doctor has prescribed it. Do not hesitate to speak with your doctor if you experience difficulty taking Tenepride P 20/15 mg Tablet .
In some cases, you may experience hypoglycaemia. Regularly monitor your blood sugar levels while taking Tenepride P 20/15 mg Tablet . Consume sugary food or juice if you experience symptoms of hypoglycaemia, such as headache, dizziness, drowsiness, shakiness, faintness, confusion, and visual disturbances.